These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. [Japanese encephalitis in Southern Europe]. Cleton N, Koopmans M, Braks M, Van Maanen K, Reusken C. Tijdschr Diergeneeskd; 2014 Jul 01; 139(7):20-5. PubMed ID: 25090898 [Abstract] [Full Text] [Related]
64. Bagaza virus inhibits Japanese encephalitis & West Nile virus replication in Culex tritaeniorhynchus & Cx. quinquefasciatus mosquitoes. Sudeep AB, Bondre VP, George R, Ghodke YS, Aher RV, Gokhale MD. Indian J Med Res; 2015 Dec 01; 142 Suppl(Suppl 1):S44-51. PubMed ID: 26905241 [Abstract] [Full Text] [Related]
65. Development of a stable Japanese encephalitis virus replicon cell line for antiviral screening. Zhang QY, Li XD, Liu SQ, Deng CL, Zhang B, Ye HQ. Arch Virol; 2017 Nov 01; 162(11):3417-3423. PubMed ID: 28779235 [Abstract] [Full Text] [Related]
67. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus. Cao L, Fu S, Gao X, Li M, Cui S, Li X, Cao Y, Lei W, Lu Z, He Y, Wang H, Yan J, Gao GF, Liang G. PLoS Negl Trop Dis; 2016 May 01; 10(5):e0004686. PubMed ID: 27139722 [Abstract] [Full Text] [Related]
68. Inhibition of Japanese encephalitis virus infection by the host zinc-finger antiviral protein. Chiu HP, Chiu H, Yang CF, Lee YL, Chiu FL, Kuo HC, Lin RJ, Lin YL. PLoS Pathog; 2018 Jul 01; 14(7):e1007166. PubMed ID: 30016363 [Abstract] [Full Text] [Related]
69. Artificial MicroRNA-Mediated Inhibition of Japanese Encephalitis Virus Replication in Neuronal Cells. Sharma H, Tripathi A, Kumari B, Vrati S, Banerjee A. Nucleic Acid Ther; 2018 Dec 01; 28(6):357-365. PubMed ID: 30457923 [Abstract] [Full Text] [Related]
70. Serological Prevalence Against Japanese Encephalitis Virus-Serocomplex Flaviviruses in Commensal and Field Rodents in South China. Chen SW, Jiang LN, Zhong XS, Zheng XY, Ma SJ, Xiong YQ, Zhou JH, Li X, Ke XM, Zhou W, Chen Q. Vector Borne Zoonotic Dis; 2016 Dec 01; 16(12):777-780. PubMed ID: 27828763 [Abstract] [Full Text] [Related]
71. Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain. Kumar P, Krishna VD, Sulochana P, Nirmala G, Haridattatreya M, Satchidanandam V. J Gen Virol; 2004 Feb 01; 85(Pt 2):471-482. PubMed ID: 14769905 [Abstract] [Full Text] [Related]
72. Susceptibility of a North American Culex quinquefasciatus to Japanese Encephalitis Virus. Huang YJ, Harbin JN, Hettenbach SM, Maki E, Cohnstaedt LW, Barrett AD, Higgs S, Vanlandingham DL. Vector Borne Zoonotic Dis; 2015 Nov 01; 15(11):709-11. PubMed ID: 26565775 [Abstract] [Full Text] [Related]
77. Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses. Chen L, Liu Y, Wang S, Sun J, Wang P, Xin Q, Zhang L, Xiao G, Wang W. Antiviral Res; 2017 May 01; 141():140-149. PubMed ID: 28232248 [Abstract] [Full Text] [Related]